HighPoint Advisor Group’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-5,672
Closed -$206K 727
2024
Q2
$206K Buy
5,672
+49
+0.9% +$2.04K 0.01% 572
2024
Q1
$247K Buy
+5,623
New +$151K 0.02% 524

Other funds holding TNDM

HighPoint Advisor Group's TNDM Position: Q3 2024 in Review

HighPoint Advisor Group sold out of Tandem Diabetes Care (TNDM) in Q3 2024, closing a stake of 5,672 shares — an estimated $206K sold.

HighPoint Advisor Group first reported a position in TNDM in Q1 2024 and held it in 2 quarters. The position peaked at $247K in Q1 2024. 332 funds tracked by Wall St. Rank hold TNDM as of Q3 2024.

  • HighPoint Advisor Group reported no remaining Tandem Diabetes Care position as of Q3 2024 after selling out during the quarter.
  • HighPoint Advisor Group sold 5,672 Tandem Diabetes Care shares in Q3 2024, an estimated $206K.
  • HighPoint Advisor Group first reported a position in Tandem Diabetes Care in Q1 2024 and held it in 2 quarters.
  • HighPoint Advisor Group's Tandem Diabetes Care position peaked at $247K in Q1 2024.
  • 332 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2024.

Based on HighPoint Advisor Group's 13F filing for Q3 2024, filed 4 Nov 2024.